Aniracetam Reference
Educational, not medical advice reference for Aniracetam: Nootropic, Cognitive; regulatory status, evidence posture, source review, and schedule…
Plain English
- What it is
- Aniracetam is a lab-made compound in the "racetam" family, the same group as piracetam. It is not approved by the FDA in the United States, although some other countries allow it by prescription for memory and thinking problems. In the US it is sold only through research-chemical sellers and also shows up in some supplements that are not actually legal.
- What people use it for
- In the nootropic ("smart drug") community, people take it hoping for clearer thinking, better focus, and an easier flow of words. Many describe it as the fat-soluble racetam they reach for when they want a smoother, more social and mood-friendly feel than piracetam. These are personal reports, not proven effects.
- What the science shows
- The human research is small and mostly looks at older people with memory loss after a stroke or with dementia, not healthy adults. Even researchers caution that promising animal results do not guarantee the compound works in people. The popular claims that it sharpens the minds of healthy people are largely unproven.
- The catch
- Because it is not FDA-approved and is not a lawful supplement in the US, products are unregulated and their quality and contents are not checked. Its evidence base is smaller than piracetam's, and the mental benefits people chase are not well established.
Reference summary
Smaller human literature than piracetam, primarily small trials in cognitive impairment and anxiety. Lipid-soluble; pharmacokinetics differ from piracetam.
Regulatory and posture
- Categories
- Nootropic, Cognitive
- Aliases
- Draganon, Sarpul, Ampamet, Memodrin, Ro 13-5057
- Evidence posture
- human - Not FDA-approved in the US. Smaller human evidence base than piracetam. Community nootropic framing for healthy adults outruns the published trials.
- Regulatory status
- No FDA-approved aniracetam drug label. Approved in some non-US markets for memory / cognitive impairment. Sold in the US only through research-chemical channels.
- Content review status
- research reference
Selected public sources
For research and educational purposes only. Not medical advice.